{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T12:56:08Z","timestamp":1775998568277,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470289"],"award-info":[{"award-number":["81470289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Science and Technology Committee","doi-asserted-by":"publisher","award":["16JCYBJC26200"],"award-info":[{"award-number":["16JCYBJC26200"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.cyto.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:46:27Z","timestamp":1491957987000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia"],"prefix":"10.1016","volume":"94","author":[{"given":"Junhong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meili","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.04.010_b0005","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.autrev.2014.01.014","article-title":"Idiopathic aplastic anaemia: diagnosis and classification","volume":"13","author":"Dolberg","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2017.04.010_b0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.12855","article-title":"The epidemiology of acquired aplastic anaemia","volume":"93","author":"Young","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2017.04.010_b0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/asheducation-2013.1.76","article-title":"Current concepts in the pathophysiology and treatment of aplastic anaemia","author":"Young","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.cyto.2017.04.010_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cyto.2017.04.010_b0025","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1046\/j.1365-2141.2001.03212.x","article-title":"Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia","volume":"115","author":"Dufour","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cyto.2017.04.010_b0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1096-8652(200008)64:4<271::AID-AJH6>3.0.CO;2-C","article-title":"Type I and type II T-cell profiles in aplastic anaemia and refractory anaemia","volume":"64","author":"Tsuda","year":"2000","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cyto.2017.04.010_b0035","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2010-01-266098","article-title":"Th17 immune responses contribute to the pathophysiology of aplastic anaemia","volume":"116","author":"de Latour","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.04.010_b0040","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2011-11-390708","article-title":"Intrinsic impairment of CD4 (+) CD25 (+) regulatory T cells in acquired aplastic anaemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.04.010_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2009.12.001","article-title":"Abnormal immunity and stem\/progenitor cells in acquired aplastic anaemia","volume":"75","author":"Li","year":"2010","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cyto.2017.04.010_b0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3324\/haematol.2010.030536","article-title":"Cytokine signature profiles in acquired aplastic anaemia and myelodysplastic syndromes","volume":"96","author":"Feng","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2017.04.010_b0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ajh.20881","article-title":"Cytokine gene polymorphisms in acquired bone marrow failure","volume":"82","author":"Gidvani","year":"2007","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cyto.2017.04.010_b0060","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3324\/haematol.2015.126128","article-title":"Identification of novel microRNA signatures linked to acquired aplastic anaemia","volume":"100","author":"Hosokawa","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2017.04.010_b0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOH.0b013e3282fa7470","article-title":"Aplastic anemia","volume":"15","author":"Young","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cyto.2017.04.010_b0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1189\/jlb.2MR0915-441R","article-title":"Biased signalling pathways via CXCR3 control the development and function of CD4+ T cell subsets","volume":"99","author":"Karin","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2017.04.010_b0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2017.04.010_b0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2017.04.010_b0085","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood-2002-12-3945","article-title":"CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK\/p44\/p42 MAPK nor Akt\/PI-3 kinase","volume":"102","author":"Smit","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.04.010_b0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/jid.2009.349","article-title":"Possible roles of IL-27 in the pathogenesis of psoriasis","volume":"130","author":"Shibata","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2017.04.010_b0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.advms.2015.07.011","article-title":"CXCL10 in psoriasis","volume":"60","author":"Ferrari","year":"2015","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.cyto.2017.04.010_b0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL) 10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2017.04.010_b0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1084\/jem.182.1.155","article-title":"Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo","volume":"182","author":"Angiolillo","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.04.010_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","article-title":"CXCR3, CXCL10 and type 1 diabetes","volume":"25","author":"Antonelli","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2017.04.010_b0115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","article-title":"The interaction between CXCL10 and cytokines in chronic inflammatory arthritis","volume":"12","author":"Lee","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2017.04.010_b0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.cyto.2017.04.010_b0125","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1572-0241.2008.02040.x","article-title":"High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection","volume":"103","author":"Antonelli","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.cyto.2017.04.010_b0130","first-page":"4396368","article-title":"The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart","author":"Altara","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cyto.2017.04.010_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cyto.2012.04.042","article-title":"Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer","volume":"59","author":"Antonelli","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.04.010_b0140","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood.V53.3.504.504","article-title":"A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anaemia","volume":"53","author":"Camitta","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.04.010_b0145","first-page":"343","article-title":"Interfering with the IFN-gamma\/CXCL10 pathway to develop new targeted treatments for vitiligo","volume":"3","author":"Rashighi","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cyto.2017.04.010_b0150","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/art.39248","article-title":"Blockade of interferon-gamma normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus","volume":"67","author":"Welcher","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cyto.2017.04.010_b0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0092-8674(90)90230-C","article-title":"Leukocyte adhesion to endothelium in inflammation","volume":"62","author":"Osborn","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2017.04.010_b0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/349691a0","article-title":"Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin","volume":"349","author":"Spertini","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2017.04.010_b0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/346425a0","article-title":"Adhesion receptors of the immune system","volume":"346","author":"Springer","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2017.04.010_b0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI9109","article-title":"C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis","volume":"106","author":"Youssef","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2017.04.010_b0175","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.168.11.5885","article-title":"Plasmid DNA encoding IFN-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis","volume":"168","author":"Wildbaum","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.04.010_b0180","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI71951","article-title":"CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis","volume":"124","author":"Zohar","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2017.04.010_b0185","first-page":"S16","article-title":"The role of the Th1 chemokine CXCL10 in vitiligo","volume":"3","author":"Antonelli","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cyto.2017.04.010_b0190","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1074\/jbc.M114.596098","article-title":"Biased signalling at chemokine receptors","volume":"290","author":"Corbisier","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2017.04.010_b0195","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1074\/jbc.M112.449587","article-title":"Biased and constitutive signalling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7","volume":"288","author":"Steen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2017.04.010_b0200","doi-asserted-by":"crossref","first-page":"42957","DOI":"10.1074\/jbc.M103933200","article-title":"The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b","volume":"276","author":"Martinelli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2017.04.010_b0205","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2014-01-549527","article-title":"IFN-\u03b3 causes aplastic anaemia by altering hematopoietic stem\/progenitor cell composition and disrupting lineage differentiation","volume":"124","author":"Lin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.04.010_b0210","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood-2005-10-4201","article-title":"T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anaemia","volume":"107","author":"Solomou","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.04.010_b0215","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood-2011-08-368308","article-title":"Functional characterization of CD4+ T cells in aplastic anaemia","volume":"119","author":"Kordasti","year":"2012","journal-title":"Blood"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617300959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617300959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:09:14Z","timestamp":1657238954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617300959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":43,"alternative-id":["S1043466617300959"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.04.010","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-inflammatory effects of the Th1 chemokine CXCL10 in acquired aplastic anaemia","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}